127
Views
39
CrossRef citations to date
0
Altmetric
Original Research

Improvement of fluvastatin bioavailability by loading on nanostructured lipid carriers

&
Pages 5797-5804 | Published online: 16 Sep 2015

References

  • Lopes-VirellaMFVirellaGTU.S. Patent and Trademark OfficeWashington DC2013U.S. Patent No8,568,995
  • YanoMIkedaMAbeKOxidative stress induces anti-hepatitis C virus status via the activation of extracellular signal-regulated kinaseHepatology200950367868819492433
  • KahJWüstenbergAKellerADSelective induction of apoptosis by HMG-CoA reductase inhibitors in hepatoma cells and dependence on p53 expressionOncol Rep20122831077108322710979
  • LeeCKChoiJSBangJSEffects of fluvastatin on the pharmacokinetics of repaglinide: possible role of CYP3A4 and P-glycoprotein inhibition by fluvastatinKorean J Physiol Pharmacol201317324525123776402
  • EkambaramPAbdul Hasan SathaliAPriyankaKSolid lipid nanoparticles: a reviewSci Rev Chem Commun20122180102
  • LiuZZhangXWuHPreparation and evaluation of solid lipid nanoparticles of baicalin for ocular drug delivery system in vitro and in vivoDrug Dev Ind Pharm201137447548121054217
  • ElshafeeyABendasEMohamedOIntranasal microemulsion of sildenafil citrate: in vitro evaluation and in vivo pharmacokinetic study in rabbitsAAPS Pharm Sci Tech2009102361367
  • ZhangYHuoMZhouJXieSPKSolver: an add-in program for pharmacokinetic and pharmacodynamic data analysis in microsoft excelComput Methods Programs Biomed20109930631420176408
  • GonzalezOIriarteGRicoELC–MS/MS method for the determination of several drugs used in combined cardiovascular therapy in human plasmaJ Chromatogr B Analyt Technol Biomed Life Sci20108782826852692
  • KochSPohlPCobetURainovNGUltrasound enhancement of liposome-mediated cell transfection is caused by cavitation effectsUltrasound Med Biol200026589790310942837
  • RawatMSinghDSarafSSarafSLipid carriers: a versatile delivery vehicle for proteins and peptidesYakugaku Zasshi2008128226928018239375
  • AburahmaMHBadr-EldinSMCompritol 888 ATO: a multifunctional lipid excipient in drug delivery systems and nanopharmaceuticalsExpert Opin Drug Deliv201411121865188325152197
  • DasSNgWKTanRBAre nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs?Eur J Pharm Sci201247113915122664358
  • BallantyneCMPazzucconiFPintóXEfficacy and tolerability of fluvastatin extended-release delivery system: a pooled analysisClin Ther200123217719211293552
  • BerklandCKimKPackDWFabrication of PLG microspheres with precisely controlled and monodisperse size distributionsJ Control Release200173597411337060
  • BrazelCSPeppasNAModeling of drug release from swellable polymersEur J Pharm Biopharm200049475810613927
  • FranssenOStenekesRJHenninkWEControlled release of a model protein from enzymatically degrading dextran microspheresJ Control Release19995921922810332056
  • OnedaFReMIThe effect of formulation variables on the dissolution and physical properties of spray-dried microspheres containing organic saltsPowder Technol2003130377384
  • AraujoLSheppardMLöbenbergRKreuterJUptake of PMMA nanoparticles from the gastrointestinal tract after oral administration to rats: modification of the body distribution after suspension in surfactant solutions and in oil vehiclesInt J Pharm1999176209224
  • HosnyKMAliSMNovel controlled release oxypentifylline microspheres; preparation, characterization and in-vivo evaluationAfr J Pharm Pharmacol201262720392048